If you’re only broadly aware that ctDNA is something people are talking about, then read on.

ctDNA stories are some of the most popular stories we publish on our website. If any of you missed our liquid biopsies webinar with Gary Pestano, that’s a great place to start familiarising yourself with the basic premise and how it’s applied to diagnostics. Broadly speaking, ctDNA is single- or double-stranded DNA released by tumour cells into the blood. It can be detected in tiny amounts, and offers several advantages over traditional tissue biopsy methods. Using it as a biomarker makes for a highly sensitive and specific tool to not only detect cancer earlier, but also change how we approach tumour management.

Participants

Gary Pestano,
Vice President of Product Development & Operations at Biodesix 
Christopher Abbosh,
TRACERx Clinical Fellow at University College London
Muhammed Murtaza,
Assistant Professor at TGen & Mayo Clinic
Rick Lanman,
Chief Medical Officer at Guardant Health 
Landon Olp,
R&D Scientist, Streck
George Karlin-Neumann,
Director of Scientific Affairs, Digital Biology Centre, Bio-Rad  

Download Roundtable